AN93: OTHER MEDICAL - ADVANCED DEVELOPMENT
Figures are FPDS award actions reporting this code.
Research and development code
Inactive
Overview
- FY2026 obligations
- $20.03M
- $20,034,175awarded under AN93
- FY2026 awards
- 14
- awards with an action under this code
- Open notices
- 0
- open SAM.gov notices classified under AN93
Obligations by fiscal year of action
- FY2026: $20,034,175
- FY2025: $3,582,264
- FY2024: -$68,253 (de-obligation)
- FY2023: -$4,996,758 (de-obligation)
- FY2022: $4,146,398
Total across 5 fiscal years: $22,697,828
Net de-obligation in that fiscal year (obligations withdrawn).
Source: FPDS award actions reporting this PSC. Obligations are the sum of the obligation on each action (modifications included). Department of Defense actions appear about 90 days after they are signed.
Definition
- Official name
- OTHER MEDICAL - ADVANCED DEVELOPMENT
- Short name
- R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT)
- Status
- Inactive since October 29, 2020
Top buying agencies
FY2024–FY2026 · awarding sub-tier agencies
| Rank | Agency | Obligated | |
|---|---|---|---|
| 1 | Defense Health Agency | $24,642,884 | 100% |
| 2 | Department Of The Air Force | $43,409 | 0.2% |
Top vendors
FY2024–FY2026
| Rank | Vendor | Obligated | ||
|---|---|---|---|---|
| 1 | MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM | $20,034,175 | 12 | 85.1% |
| 2 | WESTAT, INC. | $6,020,174 | 1 | 25.6% |
| 3 | KBR WYLE SERVICES, LLC | $43,409 | 7 | 0.2% |